- Home
- ABEO vs HRZN Comparison
ABEO vs HRZN Comparison
Compare ABEO & HRZN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | ABEO | HRZN |
|---|---|---|
| Founded | 1974 | 2008 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance/Investors Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 280.2M | 295.1M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | ABEO | HRZN |
|---|---|---|
| Price | $4.95 | $4.04 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 4 | 5 |
| Target Price | ★ $18.75 | $6.80 |
| AVG Volume (30 Days) | 1.0M | ★ 1.4M |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | ★ 32.20% |
| EPS Growth | ★ 38.74 | N/A |
| EPS | ★ 1.35 | N/A |
| Revenue | ★ $2,998,000.00 | N/A |
| Revenue This Year | N/A | $19.99 |
| Revenue Next Year | $1,589.77 | $27.95 |
| P/E Ratio | $3.53 | ★ N/A |
| Revenue Growth | ★ 258.18 | N/A |
| 52 Week Low | $3.93 | $4.00 |
| 52 Week High | $7.54 | $9.52 |
Technical Indicators
Market Signals| Indicator | ABEO | HRZN |
|---|---|---|
| Relative Strength Index (RSI) | 46.91 | 18.30 |
| Support Level | $4.87 | $4.00 |
| Resistance Level | $5.60 | $6.81 |
| Average True Range (ATR) | 0.20 | 0.27 |
| MACD | -0.02 | -0.14 |
| Stochastic Oscillator | 27.73 | 1.89 |
Price Performance
Historical ComparisonAbout ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel.
About HRZN Horizon Technology Finance Corporation
Horizon Technology Finance Corp is a specialty finance company. Its investment objective is to maximize its investment portfolio's total return by generating current income from the debt investments it makes and capital appreciation from the warrants it receives when making such debt investments. It lends to and invests in development-stage companies in the technology, life science, healthcare information and services, and sustainability industries.